Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aclaris Therapeutics

1.28
-0.1600-11.11%
Post-market: 1.27-0.0100-0.78%19:18 EDT
Volume:384.00K
Turnover:511.84K
Market Cap:138.60M
PE:-0.75
High:1.45
Open:1.44
Low:1.28
Close:1.44
Loading ...
Dec 03, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 21, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 21, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 31, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Oct 17, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Oct 15, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Oct 11, 2019

Major Issues Report

Current report, items 1.01, 1.02, 2.01, 7.01, and 9.01
Sep 27, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 09, 2019

Major Issues Report

Current report, item 5.02
Sep 05, 2019

Major Issues Report

Current report, items 2.05, 7.01, and 9.01
Aug 29, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 31, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jul 30, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jul 29, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities